Comparison of the Effects of TIVA vs VIMA on Content of GSK-3beta in Leucocytes in On-pump Patients

M

Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy

Status and phase

Terminated
Phase 4

Conditions

Glycogen Synthase Kinase 3

Treatments

Drug: Propofol
Drug: Sevoflurane

Study type

Interventional

Funder types

Other

Identifiers

NCT02686710
GSK-TV-L

Details and patient eligibility

About

Assessment of GSK-3beta contents in leukocytes in on-pump cardiosurgical patients receiving either volatile or intravenous anesthesia

Enrollment

10 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

elective on-pump CABG

Exclusion criteria

re-operation

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

10 participants in 3 patient groups

VIMA
Active Comparator group
Description:
Patiens receiving volatile induction and maitenance of anesthesia
Treatment:
Drug: Sevoflurane
TIVA
Active Comparator group
Description:
Patiens receiving total intravenous anesthesia based on propofol
Treatment:
Drug: Propofol
Combi
Active Comparator group
Description:
Patiens receiving total intravenous induction and volatile anesthesia
Treatment:
Drug: Sevoflurane
Drug: Propofol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems